Biogen Alum Put in Charge of Raising Bain Capital's First Life Science Investment Fund

Published: Nov 23, 2016

Bain Capital is looking to raise an undisclosed amount of money for an investment fund focused on life sciences companies, according to a regulatory filing on Tuesday.

The filing indicates that the Boston-based investment firm has not raised any money to date, but lists Bain Capital Life Sciences managing directors Adam M. Koppel and Jeffrey Schwartz. Koppel rejoined Bain in June after two years at Biogen, one of the state's leading life sciences companies, according to his LinkedIn profile.

Back to news